fda compounding semaglutide warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA and Novo Nordisk Warn

One of the biggest problems with the term microdosing, as it pertains to GLP-1s, Levy says, is that its vague, and theres no consensus on what its referring to

GLP-1 receptor agonists mimic a natural hormone called glucagon-like peptide-1

This is the low-dose initiation phase where your body begins recognizing the medication

Table of adverse effects at pivotal doses The dysesthesia signal of retatrutide: a serious point This is a new finding that no comparative study conducted before 2026 had included

Researchers using the tirzepatide dosage calculator to dial in their protocols often find that the difference between day 2 effects and day 6 effects is more noticeable than with semaglutide

Combining GLP-1s with other weight loss medications like phentermine requires specific medical oversight